Related references
Note: Only part of the references are listed.Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options
J. C. O. Sardi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Michael A. Pfaller
AMERICAN JOURNAL OF MEDICINE (2012)
Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex
Adriana Lopes Motta et al.
Brazilian Journal of Infectious Diseases (2012)
Time to positivity of blood cultures of different Candida species causing fungaemia
Chih-Cheng Lai et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Transcriptional Profiling of Azole-Resistant Candida parapsilosis Strains
A. P. Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comprehensive characterization of secreted aspartic proteases encoded by a virulence gene family in Candida albicans
Wataru Aoki et al.
JOURNAL OF BIOCHEMISTRY (2011)
Antifungal Susceptibility and Virulence Attributes of Bloodstream Isolates of Candida from Hong Kong and Finland
C. J. Seneviratne et al.
MYCOPATHOLOGIA (2011)
Enhancement of Secretory Aspartyl Protease production in biofilms of Candida albicans exposed to sub-inhibitory concentrations of fluconazole
Alinne Ulbrich Mores et al.
MYCOSES (2011)
Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model
Bettina Schulz et al.
MYCOSES (2011)
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida Time for harmonization of CLSI and EUCAST broth microdilution methods
M. A. Pfaller et al.
DRUG RESISTANCE UPDATES (2010)
Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans
Rohitashw Kumar et al.
FUNGAL BIOLOGY (2010)
Potential virulence factors of Candida spp. isolated from clinical and food sources
E. Costa et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Silicone colonization by non-Candida albicans Candida species in the presence of urine
Sonia Silva et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Effects of Antifungal Agents in Sap Activity of Candida albicans Isolates
Carolina Rodrigues Costa et al.
MYCOPATHOLOGIA (2010)
Adhesive Properties and Hydrolytic Enzymes of Oral Candida albicans Strains
Emira Noumi et al.
MYCOPATHOLOGIA (2010)
DIFFERENCES IN EXOENZYME PRODUCTION AND ADHERENCE ABILITY OF Candida spp. ISOLATES FROM CATHETER, BLOOD AND ORAL CAVITY
Carolina Rodrigues Costa et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2010)
Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
L. A. Braga-Silva et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
David L. Horn et al.
CLINICAL INFECTIOUS DISEASES (2009)
Lost in Translation: Differences in Antimicrobial Indication Approval Policies Between the United States and Europe
Georgios Pappas et al.
CLINICAL THERAPEUTICS (2009)
Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium
Sonia Silva et al.
EUROPEAN JOURNAL OF ORAL SCIENCES (2009)
Antifungal drug resistance mechanisms
Javier Peman et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
The Glycosylphosphatidylinositol-Anchored Protease Sap9 Modulates the Interaction of Candida albicans with Human Neutrophils
Anke Hornbach et al.
INFECTION AND IMMUNITY (2009)
Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species
B. Parra-Ortega et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis
Julian R. Naglik et al.
MICROBIOLOGY-SGM (2008)
Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans
Ulrich Lermann et al.
MICROBIOLOGY-SGM (2008)
Biofilm lifestyle of Candida: a mini review
C. J. Seneviratne et al.
ORAL DISEASES (2008)
Candida BLOODSTREAM INFECTION: DATA FROM A TEACHING HOSPITAL IN MATO GROSSO DO SUL, BRAZIL
Marilene Rodrigues Chang et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2008)
Azole antifungals induce up-regulation of SAP4, SAP5 and SAP6 secreted proteinase genes in filamentous Candida albicans cells in vitro and in vivo
Caroline J. Barelle et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis
Cui Hong Lian et al.
MYCOSES (2007)
Candida albicans Biofilms produce more secreted aspartyl protease than the planktonic cells
Aline Mendes et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata
Rupinder Kaur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular mechanism of flucytosine resistance in Candida lusitaniae: Contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance
Nicolas Papon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Virulence factors for Candida spp recovered from intravascular catheters and hospital workers' hands
Nathalie Kira Tamura et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2007)
Echinocandins for candidemia in adults without neutropenia
John E. Bennett
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Epidemiology of candidemia in Brazil:: a nationwide sentinel surveillance of candidemia in eleven medical Centers
Arnaldo L. Colombo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Candidaemia in Europe: epidemiology and resistance
Anna Maria Tortorano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions
A Albrecht et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis
DHMLP Navarathna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients
M Dagdeviren et al.
MYCOSES (2005)
Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes
VMS Copping et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program
RA Hajjeh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
A sensitive predictor for potential GPI lipid modification sites in fungal protein sequences and its application to genome-wide studies for Aspergillus nidulans, Candida albicans Neurospora crassa, Saccharomyces cerevisiae and Schizosaccharomyces pombe
B Eisenhaber et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms
CB Green et al.
MICROBIOLOGY-SGM (2004)
Guidelines for treatment of candidiasis
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2004)
Candida albicans proteinases and host/pathogen interactions
J Naglik et al.
CELLULAR MICROBIOLOGY (2004)
Secreted aspartate proteinases, a virulence factor of Candida spp.: Occurrence among clinical isolates
P Hamal et al.
FOLIA MICROBIOLOGICA (2004)
A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2003)
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis
JR Naglik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections
JR Naglik et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium
HC Korting et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium
M Schaller et al.
INFECTION AND IMMUNITY (2003)
Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals
AL Colombo et al.
MEDICAL MYCOLOGY (2003)
Infectious disease 2001: drug resistance, new drugs
NH Georgopapadakou
DRUG RESISTANCE UPDATES (2002)
Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro
JS Ripeau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Effect of micafungin (FK463) on Candida albicans adherence to epithelial cells
M Borg-von Zepelin et al.
CHEMOTHERAPY (2002)
Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases SAP4 to SAP6 are required for the invasion of parenchymal organs
A Felk et al.
INFECTION AND IMMUNITY (2002)
Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains
AS Kantarcioglu et al.
MYCOSES (2002)
The lipase/acyltransferase from Candida parapsilosis - Molecular cloning and characterization of purified recombinant enzymes
V Neugnot et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Candida albicans proteinases:: resolving the mystery of a gene family
B Hube et al.
MICROBIOLOGY-SGM (2001)
Virulence factors of Candida albicans
RA Calderone et al.
TRENDS IN MICROBIOLOGY (2001)
Antifungal proteins
CP Selitrennikoff
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae -: Inhibition with peptidomimetic inhibitors
I Pichová et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Evaluation of etest for direct antifungal susceptibility testing of yeasts in positive blood cultures
HC Chang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Effect of fluconazole on agar invasion by Candida albicans
DP Kontoyiannis et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2001)
Secreted aspartic proteinase family of Candida tropicalis
C Zaugg et al.
INFECTION AND IMMUNITY (2001)
Microbial biofilms: from ecology to molecular genetics
ME Davey et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
A Vermes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS
M Ruhnke et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Role of hyphal formation in interactions of Candida albicans with endothelial cells
QT Phan et al.
INFECTION AND IMMUNITY (2000)
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750
F Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole
T Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans
KC Hazen et al.
FEMS MICROBIOLOGY LETTERS (2000)
Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans
K Fekete-Forgacs et al.
MYCOSES (2000)
Share Paper
